257 related articles for article (PubMed ID: 29200030)
1. Resveratrol for patients with chronic obstructive pulmonary disease: hype or hope?
Beijers RJHCG; Gosker HR; Schols AMWJ
Curr Opin Clin Nutr Metab Care; 2018 Mar; 21(2):138-144. PubMed ID: 29200030
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Resveratrol on Inflammation and Oxidative Stress in a Rat Model of Chronic Obstructive Pulmonary Disease.
Wang XL; Li T; Li JH; Miao SY; Xiao XZ
Molecules; 2017 Sep; 22(9):. PubMed ID: 28895883
[TBL] [Abstract][Full Text] [Related]
3. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.
Brassington K; Selemidis S; Bozinovski S; Vlahos R
Clin Sci (Lond); 2019 Apr; 133(7):885-904. PubMed ID: 30979844
[TBL] [Abstract][Full Text] [Related]
4. Curcumin attenuates skeletal muscle mitochondrial impairment in COPD rats: PGC-1α/SIRT3 pathway involved.
Zhang M; Tang J; Li Y; Xie Y; Shan H; Chen M; Zhang J; Yang X; Zhang Q; Yang X
Chem Biol Interact; 2017 Nov; 277():168-175. PubMed ID: 28951138
[TBL] [Abstract][Full Text] [Related]
5. Bufei Jianpi granules improve skeletal muscle and mitochondrial dysfunction in rats with chronic obstructive pulmonary disease.
Dong Y; Li Y; Sun Y; Mao J; Yao F; Tian Y; Wang L; Li L; Li S; Li J
BMC Complement Altern Med; 2015 Mar; 15():51. PubMed ID: 25888379
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease.
Biswas S; Hwang JW; Kirkham PA; Rahman I
Curr Med Chem; 2013; 20(12):1496-530. PubMed ID: 22963552
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease.
Wiegman CH; Michaeloudes C; Haji G; Narang P; Clarke CJ; Russell KE; Bao W; Pavlidis S; Barnes PJ; Kanerva J; Bittner A; Rao N; Murphy MP; Kirkham PA; Chung KF; Adcock IM;
J Allergy Clin Immunol; 2015 Sep; 136(3):769-80. PubMed ID: 25828268
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant therapeutic targets in COPD.
Rahman I; Kilty I
Curr Drug Targets; 2006 Jun; 7(6):707-20. PubMed ID: 16787173
[TBL] [Abstract][Full Text] [Related]
9. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
Hatzelmann A; Morcillo EJ; Lungarella G; Adnot S; Sanjar S; Beume R; Schudt C; Tenor H
Pulm Pharmacol Ther; 2010 Aug; 23(4):235-56. PubMed ID: 20381629
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol and metabolic health in COPD: A proof-of-concept randomized controlled trial.
Beijers RJ; Gosker HR; Sanders KJ; de Theije C; Kelders M; Clarke G; Cryan JF; van den Borst B; Schols AM
Clin Nutr; 2020 Oct; 39(10):2989-2997. PubMed ID: 31996311
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant therapeutic advances in COPD.
Rahman I
Ther Adv Respir Dis; 2008 Dec; 2(6):351-74. PubMed ID: 19124382
[TBL] [Abstract][Full Text] [Related]
12. Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.
Tse HN; Tseng CZ
Int J Chron Obstruct Pulmon Dis; 2014; 9():825-36. PubMed ID: 25125976
[TBL] [Abstract][Full Text] [Related]
13. Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD.
Cazzola M; Page CP; Wedzicha JA; Celli BR; Anzueto A; Matera MG
Respir Res; 2023 Jul; 24(1):194. PubMed ID: 37517999
[TBL] [Abstract][Full Text] [Related]
14. The phosphodiesterase-4 inhibitor roflumilast reverts proteolysis in skeletal muscle cells of patients with COPD cachexia.
Barreiro E; Puig-Vilanova E; Salazar-Degracia A; Pascual-Guardia S; Casadevall C; Gea J
J Appl Physiol (1985); 2018 Aug; 125(2):287-303. PubMed ID: 29648516
[TBL] [Abstract][Full Text] [Related]
15. A systemic review on the antioxidant and anti-inflammatory effects of resveratrol, curcumin, and dietary nitric oxide supplementation on human cardiovascular health.
Banez MJ; Geluz MI; Chandra A; Hamdan T; Biswas OS; Bryan NS; Von Schwarz ER
Nutr Res; 2020 Jun; 78():11-26. PubMed ID: 32428778
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Resveratrol on the Cardiovascular System from Molecular Mechanisms to Clinical Results.
Gal R; Deres L; Toth K; Halmosi R; Habon T
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576315
[TBL] [Abstract][Full Text] [Related]
17. [Resveratrol attenuates endoplasmic reticulum stress and alveolar epithelial apoptosis in a rat model of chronic obstructive pulmonary disease].
Li Y; Luo B; Zhang L; Ma M; Guo X
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jan; 37(1):30-5. PubMed ID: 24694971
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol alleviates lung ischemia and reperfusion-induced pulmonary capillary injury through modulating pulmonary mitochondrial metabolism.
Yeh DY; Fu YH; Yang YC; Wang JJ
Transplant Proc; 2014 May; 46(4):1131-4. PubMed ID: 24815145
[TBL] [Abstract][Full Text] [Related]
19. Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities.
Bernardo I; Bozinovski S; Vlahos R
Pharmacol Ther; 2015 Nov; 155():60-79. PubMed ID: 26297673
[TBL] [Abstract][Full Text] [Related]
20. Multi-target natural products as alternatives against oxidative stress in Chronic Obstructive Pulmonary Disease (COPD).
Gonçalves PB; Romeiro NC
Eur J Med Chem; 2019 Feb; 163():911-931. PubMed ID: 30612088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
